Prophylactic role of melatonin against radiation induced damage in mouse cerebellum with special reference to Purkinje cells.
Melatonin, a hormone with a proven antioxidative efficacy, crosses all morphophysiological barriers, including the blood-brain barrier, and distributes throughout the cell. The present study is an attempt to investigate the prophylactic influence of a chronic low level of melatonin against an acute radiation induced oxidative stress in the cerebellum of Swiss albino mice, with special reference to Purkinje cells. After 15 days of treatment the mice were sacrificed at various intervals from 1 to 30 days. Biochemical parameters included lipid peroxidation (LPO) and glutathione (GSH) levels as the endpoints. The quantitative study included alterations in number and volume of Purkinje cells. Swiss albino mice were orally administered a very low dose of melatonin (0.25 mg/mouse/day) for 15 consecutive days before single exposure to 4 Gy gamma radiation. Melatonin checked the augmented levels of LPO, by approximately 55%, by day 30 day post-exposure. Radiation induced depleted levels of GSH could be raised by 68.9% by day 30 post-exposure. Radiation exposure resulted in a reduction of the volume of Purkinje cells and their total number. The administration of melatonin significantly protected against the radiation induced decreases in Purkinje cell volume and number. Results indicate the antioxidative properties of melatonin resulting in its prophylactic property against radiation induced biochemical and cellular alterations in the cerebellum. The findings support the idea that melatonin may be used as an anti-irradiation drug due to its potent free radical scavenging and antioxidative efficacy.
Sisodia
Rashmi
R
Neurobiology Laboratory, Department of Zoology, University of Rajasthan, Jaipur 302004, India. rashsisodia@yahoo.co.in
Kumari
Seema
S
Verma
Rajesh Kumar
RK
Bhatia
A L
AL
D000818:Animals; D001930:Brain Injuries / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D002478:Cells, Cultured; D002531:Cerebellum / Q000187:drug effects* / Q000293:injuries / Q000473:pathology; D008297:Male; D008550:Melatonin / Q000008:administration & dosage*; D051379:Mice; D011689:Purkinje Cells / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology*; D011832:Radiation Injuries / Q000473:pathology* / Q000517:prevention & control*; D011836:Radiation Tolerance / Q000187:drug effects; D016896:Treatment Outcome
D008550:Melatonin